Avoro Capital Advisors’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-598,600
| Closed | -$17.6M | – | 43 |
|
|
2024
Q3 | $17.6M | Sell |
598,600
-1,240,538
| -67% | -$36.5M | 0.26% | 33 |
|
|
2024
Q2 | $43.2M | Hold |
1,839,138
| – | – | 0.58% | 29 |
|
|
2024
Q1 | $69.8M | Hold |
1,839,138
| – | – | 0.81% | 26 |
|
|
2023
Q4 | $39.6M | Buy |
1,839,138
+1,827,680
| +15,951% | +$39.3M | 0.55% | 25 |
|
|
2023
Q3 | $140K | Hold |
11,458
| – | – | ﹤0.01% | 45 |
|
|
2023
Q2 | $129K | Buy |
+11,458
| New | +$129K | ﹤0.01% | 43 |
|